baber/WOPTO huggingface dataset:
Patent NZ-522199-A (NZ)
Title: A powered applicator
Inventor: BUNYAN GLENN WALTER
IPC: A61M5/20
Filed: 2002-10-24
Abstract: A powered injector (10) that includes a solenoid (23) that moves a piston (16) to cause a liquid to be injected via the needle (13). A shroud (27) engages a switch (28) to cause electric energy to be delivered to the solenoid (24) to cause actuation thereof.
Patent NZ-523017-A (NZ)
Title: Compounds and compositions for delivering active agents and preparation method thereof
Inventor: WEIDNER JOHN J
IPC: C07C235/52
Filed: 2001-06-29
Abstract: Compounds of formula (I), their compositions for the delivery of active agents, methods of administration and preparation of these compounds are disclosed. The compounds described herein may be derived from amino acids, wherein the compounds may be prepared by reacting the single amino acid with the appropriate acylating or amine-modifying agent, which reacts with a free amino moiety present in the amino acid to form amides. Protecting groups may be used to avoid unwanted side reactions. These compounds may be purified by recrystallization or by fractionation on one or more solid chromatographic supports, alone or linked in tandem.
Patent NZ-524698-A (NZ)
Title: Patient oxygen delivery system
Inventor: LAVIMODIERE MAURICE
IPC: A61M16/10
Filed: 2001-05-07
Abstract: A lightweight oxygen delivery system for a patient comprising a curved resilient headband to extend from side to side over a patient's head and to be comfortably seatably engaged thereon. A clip is secured towards one end of the headband. An elongated tubular boom is secured at one end to the clip to extend and hold its position, when in operation from said one end at the clip to another end located at a space in front of, and proximal to the patient's nose and mouth. An oxygen diffuser port is located at the other end of the boom, to deliver oxygen from the boom to the space in the vicinity of the patient's nose and mouth. The clip is constructed so as to hold securely an oxygen delivery tube from an oxygen source in fluid communication with said one end of the boom so as to deliver oxygen from the source to the boom for discharge through the diffuser. the tubular boom is secured within the sleeve for telescopic, longitudinal adjustment of the boom with respect to the sleeve to facilitate positioning of the oxygen diffuser with respect to the patient's nose and mouth
Patent NZ-530750-A (NZ)
Title: Novel thiophene carboxamide compounds and their use as pharmaceuticals
Inventor: FAULL ALAN
IPC: A61K31/4439
Filed: 2002-07-19
Abstract: Thiophene carboxamide derivatives of formula I, processes for their preparation and intermediates used in their preparation, pharmaceutical compositions containing them and their uses in therapy are disclosed. The compounds disclosed are useful in the manufacture of a medicament for use in the treatment or prophylaxis of diseases or conditions in which inhibition of IKK-2 activity is beneficial. In particular, the disclosed compounds are useful in the treatment of: -inflammatory disease -asthma -rheumatoid arthritis -multiple sclerosis -chronic obstructive pulmonary disease and -cancer.
Patent NZ-533115-A (NZ)
Title: Controlled release polymeric compositions of bone growth promoting compounds
Inventor: DUMONT FRANCIS
IPC: A61K9/00
Filed: 2002-11-20
Abstract: A system for controlled release of a bone growth promoting compound and a flowable composition for its formation is disclosed, wherein the flowable composition is composed of a bone growth promoting compound, a biodegradable thermoplastic polymer and a biocompatible organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
Patent NZ-535713-A (NZ)
Title: Programmable breastpump with milk letdown sequence and other special sequences
Inventor: SILVER BRIAN H
IPC: A61M1/06
Filed: 2000-12-07
Abstract: A breastpump which can be programmed to generate a plurality of differing milk expression (extraction) sequences, or curves. In one embodiment of the invention, a motorized pump (e.g., compressed air, battery and/or house current) is provided with a microprocessor-based controller. Cards with microprocessor 'chips' containing different suction curves adapted for varying conditions and objectives are included for programming the controller in this embodiment.
Patent NZ-542329-A (NZ)
Title: Overvoltage protection magazine for a device of telecommunications technology
Inventor: NEUMETZLER HEIKO
IPC: H01T4/06
Filed: 2004-03-26
Abstract: An overvoltage protection magazine for a telecommunications device, comprising a housing, a printed circuit board, two or more surge arrestors and at least one ground contact, the surge arrestors, being arranged on the printed circuit board and being passed via conductor tracks to contact pads arranged on the printed circuit board which, when plugged in, come into electrical contact with contacts of the telecommunications device, the surge arrestors being arranged in a row, wherein the printed circuit board is structured in the lower region such that it has cutouts, forming plug-in regions corresponding to the number of surge arrestors, for each plug-in region the two outer electrodes of the surge arrestor associated with it being guided by conductor tracks, a contact pad for each outer electrode being arranged in the edge region of the printed circuit board, said contact pads being arranged on the front and rear of the printed circuit board.
Patent NZ-543656-A (NZ)
Title: Use of HIF alpha stabilizers for enhancing erythropoiesis
Inventor: KLAUS STEPHEN J
IPC: A61K31/00
Filed: 2004-06-04
Abstract: Provided is the use of an inhibitor of HIF prolyl hydroxylase that is a heterocyclic carbonyl glycine in the manufacture of a medicament for treating anemia of chronic disease in a subject. Further provided is similar use of specified derivatives of the heterocyclic carbonyl glycine and corresponding pharmaceutical compositions.
Patent NZ-543896-A (NZ)
Title: Safety system for an elevator structure
Inventor: DEPLAZES ROMEO
IPC: B66B5/00
Filed: 2004-06-25
Abstract: A safety system for an elevator structure is disclosed. The safety system comprises a control unit 11, a bus node 13, a safety element 16, and a bus 12 for enabling communication between the control unit and the bus node. The bus node is provided with a first circuitry means 14 which impinge the safety element with a first analogue signal upon a digital input by the control unit. The bus node is also provided with secondary circuitry means 15 which pick an analogue signal on the safety element and supply digital feedback data to the control unit via the bus.
Patent NZ-546586-A (NZ)
Title: Resolution of 3-amino alkylnitriles
Inventor: COLBERG JUAN CARLOS
IPC: A61K31/405
Filed: 2004-10-18
Abstract: Disclosed are chiral N-acetyl-alpha amino acid salts of formula I wherein R is methyl, ethyl, n-propyl, isopropyl, n-butyl, or isobutyl and Q is N-acetyl-L-alanine, N-acetyl-L-arginine, N-acetyl-L-asparagine, N-acetyl-L-aspartic acid, N-acetyl-L-cysteine, N-acetyl-L-glutamine, N-acetyl-L-glutamic acid, N-acetyl-L-histidine, N-acetyl-L-isoleucine, N-acetyl-L-Ieucine, N-acetyl-L-Iysine, N-acetyl-L-methionine, N-acetyl-L-phenylalamine, N-acetyl-L-proline, N-acetyl-L-serine, N-acetyl-L-threonine, N-acetyl-L-tryptophan, N-acetyl-L-tyrosine, N-acetyl-Lvaline, N-acetyl-D-alanine, N-acetyl-D-arginine, N-acetyl-D-asparagine, N-acetyl-D-aspartic acid, N-acetyl-D-cysteine, N-acetyl-D-glutamine, N-acetyl-D-glutamic acid, N-acetyl-D-histidine, N-acetyl-D-isoleucine, N-acetyl-D-Ieucine, N-acetyl-D-Iysine, N-acetyl-D-methionine, N-acetyl-D-phenylalamine, N-acetyl-D-proline, N-acetyl-D-serine, N-acetyl-D-threonine, N-acetyl-D-tryptophan, N-acetyl-D-tyrosine, or Nacetyl-D-valine. Also disclosed is a process for preparing optically active beta-amino alkylnitriles by resolving racemic beta-amino alkylnitriles using chiral N-acetyl-alpha-amino acids as resolving agents.
Patent NZ-546961-A (NZ)
Title: Improved methods of in vitro protein synthesis
Inventor: CALHOUN KARA
IPC: C12N/
Filed: 2004-11-18
Abstract: A method for synthesis of polynucleotides and/or polypeptides in a cell-free reaction mixture initially comprising a bacterial cell extract comprising ribosomes, tRNAs, aminoacyl synthetases, elongation factors, initiation factors, and ribosome recycling factors; a template for production of the polynucleotides and/or polypeptide; monomers for the polynucleotides and/or polypeptide to be synthesized, and such co-factors, enzymes and other reagents that are necessary for the synthesis. The method comprises: synthesizing said polynucleotides and/or polypeptides in a cell-free reaction mixture modified to include: at least 10 mM of a phosphate-free energy source; nucleoside monophosphates in the absence of exogenous nucleoside triphosphates; and exogenous phosphate at a concentration of at least about 1 mM.
Patent NZ-551440-A (NZ)
Title: Pharmaceutical salts
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K47/20
Filed: 2002-02-28
Abstract: Disclosed is a pharmaceutical salt of a pharmaceutically active compound and at least one sugar substitute, wherein the salt form active compound is a salt-forming dimethyl-(3arylbut-3-enyl)amine compound of general formula IV as defined in the specification. Salts of the type disclosed are useful in the treatment of pain and urinary incontinence.
Patent NZ-553958-A (NZ)
Title: Ground Anchor with cable guiding means for a loop of a winch cable
Inventor: MOFFAT MILES EDWARD
Filed: 2007-03-19
Abstract: A cable guide mechanism 200, for a ground anchor 100 which can be used in moving a stranded vehicle, is configured to be releasably attached to a shaft 10. The mechanism 200 includes a body portion 15, an indent or groove and a protrusion 17. The indent or groove is located on the opposite side of the body portion 15 to the protrusion 17, and is dimensioned and configured to releasably retain an inside edge of a first distal end of a loop 19 which is attached to a terminal end of a cable 18. The protrusion 17 is tapered with its widest section directly opposite the indent or groove, and the linear distance between the bottom of the indent or groove and the widest section of the protrusion 17 is sufficiently close to the inside length of the loop 19 that in use the first distal end of the loop 19 cannot climb out of the indent or groove. The shaft 10 is configured to freely rotate coaxially inside the cable guide mechanism 200.
Patent NZ-562979-A (NZ)
Title: Pharmaceutical compositions of a pregnanone steroid which provide specific steady state plasma levels and uses thereof
Inventor: WOODWARD RICHARD M
IPC: A61K9/16
Filed: 2006-06-09
Abstract: Disclosed is a pharmaceutical composition comprising 3alpha-hydroxy-3beta-methoxymethyl-21-(1'-imidazolyl)-5alpha-pregnan-20-one (the pictured compound) or a pharmaceutically acceptable salt or solvate thereof, and one or more pharmaceutically-acceptable excipients, wherein the composition provides steady state plasma levels of the pregnanone in a range of from about 5 ng/mL to about 500 ng/mL for a duration of from about 12 h to about 24 h following administration. Also disclosed is the use of the above pharmaceutical composition for the treatment of anxiety, depression, alcohol addiction and/or dependence, premenstrual tension, premenstrual syndrome or premenstrual dysphoric disorder.
Patent NZ-564486-A (NZ)
Title: Bipolar trans carotenoid salts and their uses
Inventor: GAINER JOHN L
IPC: A61P9/10
Filed: 2003-02-25
Abstract: Disclosed is a method of converting an isomeric mixture of olefinic dialdehydes into the all trans aldehyde comprising isomerising said isomeric mixture of dialdehydes with a sulfinic acid in a solvent.
Patent NZ-565683-A (NZ)
Title: Methods for identifying agents and conditions that modulate neurogenesis in human neural cells
Inventor: BARLOW CARROLEE
IPC: A61P25/00
Filed: 2006-07-07
Abstract: Disclosed is a method for identifying an agent that modulates neurogenesis, said method comprising: exposing a monolayer cell culture consisting of human neural cells to a test agent in media containing leukemia inhibiting factor (L1F) and not containing epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), and measuring a change in the proportion of neural cells in mitosis; a change in expression of a neurogenesis marker in the neural cells; a change in the proportion of neural stem cells (NSCs) in the culture; or a change in the population of neurons or astrocytes in the culture after a period of time, wherein the period of time is several days up to 19 days, and wherein the change in the proportion of neural cells in mitosis; the change in expression of a neurogenesis marker in the neural cells; the change in the proportion of neural stem cells (NSCs) in the culture; or the change in the population of neurons or astrocytes in the culture is as compared to neural cells that have not been exposed to the test agent, and wherein the measuring of a change identifies the test agent as modulating neurogenesis in the neural cells.
Patent NZ-570712-A (NZ)
Title: 2-methylene-1alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
Inventor: DELUCA HECTOR F
IPC: A61P37/00
Filed: 2007-04-06
Abstract: Disclosed are 2-methylene-1a,25-dihydroxy-18,19,21-trinorvitamin D3 compounds as represented by the general formula I, wherein X1 and X2 are independently selected from H and hydroxy protecting groups. Further disclosed is a pharmaceutical composition which comprises an effective amount of a compound as defined above for the treatment of a biological condition selected from metabolic bone disease; psoriasis; leukaemia; colon cancer; breast cancer; prostate cancer; skin cancer; lung cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis, psoriatic arthritis, asthma, or inflammatory bowel diseases; a skin condition selected from wrinkles, lack of adequate skin firmness, lack of adequate dermal hydration, or insufficient sebum secretion; renal osteodystrophy; osteopenia; vitamin D-resistant rickets or osteoporosis.
Patent NZ-572017-A (NZ)
Title: Vaccine against nicotine addiction
Inventor: HOOGERHOUT PETER
IPC: A61K31/465
Filed: 2007-04-20
Abstract: Disclosed is a hapten in the form of nicotine derivatives wherein the formula and substituents are defined the specification. Also disclosed is suitably conjugation of the said nicotine derivatives with a carrier to yield a vaccine against nicotine addiction.
Patent NZ-574345-A (NZ)
Title: N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
Inventor: DUBOIS LAURENT
IPC: C07D401/04
Filed: 2007-07-30
Abstract: Disclosed is an indole compound of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) include: N-[6-(1-oxypyrrolidin-1-yl)pyridin-3-yl]-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide; N-[2-(Pyrrolidin-1-yl)pyrimidin-5-yl]-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide and N-[6-(3-Hydroxyazetidin-1-yl)pyridin-3-yl]-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide. Also disclosed is a pharmaceutical composition or medicament comprising a compound of formula (I); the process for making a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating pain, inflammation, urological disorders, gynaecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, irritation of the skin, eyes or mucous membranes, herpes or shingles or to treat depression or diabetes.
Patent NZ-578264-A (NZ)
Title: Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
Inventor: GOMTSYAN ARTHUR
IPC: A61K31/416
Filed: 2004-06-10
Abstract: Disclosed are compounds of formula (I), wherein X5 is N, Z1 is O, Z2 is NH and the remaining substituents are as defined in the specification. The compounds inhibit the VR1 receptor in mammals and are useful for controlling pain.
Patent NZ-585528-A (NZ)
Title: Haloallylamine inhibitors of ssao/vap-1 and uses therefor
Inventor: MCDONALD IAN ALEXANDER
IPC: A61P1/18
Filed: 2008-11-19
Abstract: Disclosed is a alkene amine compound of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) are: (E)-3-Fluoro-4-(4-(morpholinosulfonyl)phenoxy)but-2-en-1-amine, (E)-4-(4-Amino-2-fluorobut-2-enyloxy)-N,N-diisopropylbenzamide and (E)-4-(4-Amino-2-fluorobut-2-enyloxy)-N-benzylbenzamide. Also disclosed is a composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the inhibition of an amine oxidase enzyme, or SSAO/VAP-1 and/or MAO or the treatment of a condition associated with amine oxidase enzyme such as inflammation, liver diseases, asthma, COPD, ocular diseases, diabetes, stroke, psoriasis.
Patent NZ-594776-A (NZ)
Title: Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
Inventor: KITAZAWA NORITAKA
IPC: A61K31/4184
Filed: 2010-02-24
Abstract: Patent No. 594776 Disclosed is a compound of formula I, such as 8-[2-chloro-5-(5-trifluoromethylpyridine-2-yl)phenyl]-2-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridin-2-yl]-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a] pyridine, which is useful for treating Alzheimer's disease, dementia, Down's syndrome and amyloidosis.
Patent NZ-595618-A (NZ)
Title: Enzyme delivery systems and methods of preparations and use
Inventor: FALLON JOAN M
IPC: A01N25/28
Filed: 2010-04-13
Abstract: 595618 Discloses coated digestive enzyme preparations containing amylase, protease and lipase, an emulsifiable lipid coating, wherein the digestive enzyme preparation is 80% by weight of the enzyme preparation. Further relates to a pharmaceutical composition, methods of preparation and use of the systems, pharmaceutical compositions and preparations to treat persons having ADD, ADHD, autism, cystic fibrosis and other behavioural and neurological disorders.
Patent NZ-597350-A (NZ)
Title: Low-latency distribution of compressed video game or application streams over a network including multiple video streams being compressed by a shared compression unit
Inventor: PERLMAN STEPHEN G
IPC: H04N21/234
Filed: 2008-12-04
Abstract: Disclosed is an apparatus (210) for allowing remote interaction with a game or application via interactive video streams. The apparatus (210) is comprised of one or more servers (1521-1525) and a compression unit (1530). The one or more servers (1521-1525) run one or more twitch video games or applications to produce a plurality of streams of uncompressed streaming interactive video (1529). The compression unit (1530) combines the streams of uncompressed streaming interactive video (1529) produced by the servers (1521-1525) into one or more new streams of compressed interactive video (1539). The compression unit (1530) also outputs the one or more new streams of compressed interactive video (1539) for transmission over one or more switched and/or routed networks to a plurality of client devices associated with a corresponding plurality of users. The client devices do not run the one or more twitch video games or applications locally. At least one of the users is located a remote distance beyond a premises where any one of the servers (1521-1525) is located. The one or more new streams of compressed streaming interactive video (1539) are compressed such that a finite round trip latency of about 80ms or less exists between a user input and the user receiving a response to the input. At least one user interacting with at least one of the one or more twitch video games or applications then perceives that responses are as instantaneous as if the at least one or more twitch video games or applications were executing on a client device local to the at least one user.
Patent NZ-603978-A (NZ)
Title: A collapsible support base
Inventor: SMYTH ALLEN TRAVERS
IPC: E01F9/646
Filed: 2010-02-24
Abstract: Disclosed is a collapsible support base (1) for upstanding items (11). The support base (1) includes a number of legs (3a, 3b) and a sleeve (2). The sleeve (2) has a top part (6) and a bottom part (7) and receives an end of the upstanding item therein via the top part (6). The legs are pivotally attached to the sleeve. The support base is adapted to adopt at least two positions including an erected position in which the plurality of legs are positioned substantially at right angles to the sleeve, and a collapsed position in which the plurality of legs and the sleeve lie in substantially the same plane as the sleeve. Each leg is restricted from pivoting around the sleeve when the support base is in the erected position (by stops 5a, 5b). Each leg is restricted from pivoting to a position less than 90° from the plane of the sleeve in the direction of the top part of the sleeve when the support base is in the erected position.
Patent NZ-606858-A (NZ)
Title: Microemulsion paint thinner
Inventor: HAWES CHARLES L
IPC: C09D7/12
Filed: 2011-08-26
Abstract: Disclosed is a microemulsion paint thinner which includes from 5 to 25% by weight hydrocarbon solvent, 0.01 to 30% by weight glycol ether, 2 to 15% by weight carboxylic acid, 0.5 to 10% by weight of a base, and 60 to 85% by weight of water, based on the total weight of the microemulsion paint thinner wherein the carboxylic acid is partially neutralized by the base. Also disclosed is a process for thinning oil-based paint which includes mixing uncured oil-based paint and the paint thinning composition.
Patent NZ-612227-A (NZ)
Title: Vectors harboring toxic genes, methods and uses therefor
Inventor: CHEN HAIFENG
IPC: C12N15/861
Filed: 2012-10-16
Abstract: Disclosed is a nucleic acid comprising: -a sequence encoding a toxic poly-peptide; and -an intron that interrupts the sequence, whereby the intron is spliced in mammalian cells but not in insect cells to form an mRNA that is translated to form cell-toxic levels of the toxic polypeptide in mammalian cells but not in insect cells. Also disclosed is the use of the above-described nucleic acid in the manufacture of a medicament for treatment of a cancer.
Patent NZ-613063-A (NZ)
Title: Web-based color selection system
Inventor: HENRY MICHAEL J
IPC: G06K9/00
Filed: 2012-01-03
Abstract: A system for web-based colour selection is disclosed. The system includes a database (24) having a plurality of digital colour images (26) and a neutral grey background value for each of the images (26), a processor configured to receive search criteria and to identify one or more of the digital colour images (26) meeting the search criteria, and a display configured to display at least one of the identified digital colour images (26) on a neutral grey background. The brightness of the neutral grey background is determined by the neutral grey background value for the image (26) being displayed. When multiple digital colour images are displayed, the neutral grey background is determined by an average of the neutral grey background values for the displayed digital colour images. A method performed by the apparatus is also provided.